{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:51:45Z","timestamp":1760986305867,"version":"build-2065373602"},"reference-count":54,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Regional Development Fund (ERDF)","award":["1.1.1.1\/21\/A\/029"],"award-info":[{"award-number":["1.1.1.1\/21\/A\/029"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: The human gut microbiome is essential for the health of the host and is affected by antibiotics and coronavirus disease 2019 (COVID-19). The gut microbiome is recognized as a contributing factor in the development of ulcerative colitis. Specific vitamins and probiotics have been demonstrated to positively influence the microbiome by enhancing the prevalence of expected beneficial microorganisms. Materials and Methods: Forty-nine ulcerative colitis (UC) outpatients from Riga East Clinical University Hospital were enrolled in this cross-sectional study from June 2021 to December 2021. All patients were divided into groups based on history of COVID-19 (COVID-19 positive vs. COVID-19 negative) in the last six months. Information about antibiotic, probiotic, and vitamin intake were outlined, and faecal samples were collected. The MetaPhlAn v.2.6.0 tool was used for the taxonomic classification of the gut microbiome metagenome data. Statistical analysis was performed using R 4.2.1. Results: Of the 49 patients enrolled, 31 (63%) were male and 18 (37%) were female. Coronavirus disease 2019 was found in 14 (28.6%) patients in the last 6 months. Verrucomicrobia was statistically significantly lower in the COVID-19 positive group (M = 0.05; SD = 0.11) compared to the COVID-19 negative group (M = 0.5; SD = 1.22), p = 0.03. Antibiotic non-users had more Firmicutes in their microbiome than antibiotic users (p = 0.008). The most used vitamin supplement was vitamin D (N = 18), fifteen (42.9%) of the patients were COVID-19 negative and 3 (21.4%) were COVID-19 positive over the last six months (p &gt; 0.05). Vitamin C users had more Firmicutes in their gut microbiome compared to non-users (Md = 72.8 [IQR: 66.6; 78.7] vs. Md = 60.1 [IQR: 42.4; 67.7]), p = 0.01. Conclusions: Antibiotic non-users had more Firmicutes than antibiotic users in their gut microbiome. Only vitamin C had statistically significant results; in users, more Firmicutes were observed. A mild course of COVID-19 may not influence ulcerative colitis patients\u2019 gut microbiome.<\/jats:p>","DOI":"10.3390\/medicina61020284","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T05:04:33Z","timestamp":1738904673000},"page":"284","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of Vitamins, Antibiotics, Probiotics, and History of COVID-19 on the Gut Microbiome in Ulcerative Colitis Patients: A Cross-Sectional Study"],"prefix":"10.3390","volume":"61","author":[{"given":"Zane","family":"Straume","sequence":"first","affiliation":[{"name":"Gastroenterology, Hepatology and Nutrition Clinic, Riga East Clinical University Hospital, LV-1038 Riga, Latvia"},{"name":"Department of Internal Diseases, Riga Stradins University, LV-1007 Riga, Latvia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikola","family":"Kr\u016bmi\u0146a","sequence":"additional","affiliation":[{"name":"Department of Internal Diseases, Riga Stradins University, LV-1007 Riga, Latvia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4381-885X","authenticated-orcid":false,"given":"Ilze","family":"Elbere","sequence":"additional","affiliation":[{"name":"Latvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7735-682X","authenticated-orcid":false,"given":"Maija","family":"Rozenberga","sequence":"additional","affiliation":[{"name":"Latvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3674-8822","authenticated-orcid":false,"given":"Ren\u0101rs","family":"Erts","sequence":"additional","affiliation":[{"name":"The Faculty of Medicine and Life Sciences, University of Latvia, LV-1004 Riga, Latvia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3478-5703","authenticated-orcid":false,"given":"Dace","family":"Rudz\u012bte","sequence":"additional","affiliation":[{"name":"Gastroenterology, Hepatology and Nutrition Clinic, Riga East Clinical University Hospital, LV-1038 Riga, Latvia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5945-0431","authenticated-orcid":false,"given":"Anna","family":"Proskurina","sequence":"additional","affiliation":[{"name":"Department of Internal Diseases, Riga Stradins University, LV-1007 Riga, Latvia"},{"name":"Pauls Stradins Clinical University Hospital, LV-1002 Riga, Latvia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelika","family":"Krumina","sequence":"additional","affiliation":[{"name":"Department of Internal Diseases, Riga Stradins University, LV-1007 Riga, Latvia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"eaao1603","DOI":"10.1126\/sciimmunol.aao1603","article-title":"Causal effects of the microbiota on immune-mediated diseases","volume":"3","author":"Round","year":"2018","journal-title":"Sci. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Wampach, L., Heintz-Buschart, A., Hogan, A., Muller, E.E.L., Narayanasamy, S., Laczny, C.C., Hugerth, L.W., Bindl, L., Bottu, J., and Andersson, A.F. (2017). Colonization and Succession within the Human Gut Microbiome by Archaea, Bacteria, and Microeukaryotes during the First Year of Life. Front. Microbiol., 8.","DOI":"10.3389\/fmicb.2017.00738"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Sohail, A., Cheema, H.A., Mithani, M.S., Shahid, A., Nawaz, A., Hermis, A.H., Chinnam, S., Nashwan, A.J., Cherrez-Ojeda, I., and Awan, R.U. (2023). Probiotics for the prevention and treatment of COVID-19: A rapid systematic review and meta-analysis. Front. Nutr., 10.","DOI":"10.3389\/fnut.2023.1274122"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The Human Intestinal Microbiome in Health and Disease","volume":"375","author":"Lynch","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1146\/annurev-immunol-093019-112348","article-title":"Control of Immunity by the Microbiota","volume":"39","author":"Ansaldo","year":"2021","journal-title":"Annu. Rev. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","article-title":"Interaction between microbiota and immunity in health and disease","volume":"30","author":"Zheng","year":"2020","journal-title":"Cell Res."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"\u015awirkosz, G., Szczygie\u0142, A., Logo\u0144, K., Wrze\u015bniewska, M., and Gomu\u0142ka, K. (2023). The Role of the Microbiome in the Pathogenesis and Treatment of Ulcerative Colitis\u2014A Literature Review. Biomedicines, 11.","DOI":"10.3390\/biomedicines11123144"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Tian, Y., Ran, H., Wen, X., Fu, G., Zhou, X., Liu, R., and Pan, T. (2023). Probiotics improve symptoms of patients with COVID-19 through gut-lung axis: A systematic review and meta-analysis. Front. Nutr., 10.","DOI":"10.3389\/fnut.2023.1179432"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41392-022-00986-0","article-title":"Alterations in microbiota of patients with COVID-19: Potential mechanisms and therapeutic interventions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4103\/2221-1691.228000","article-title":"A comprehensive review on clinical outcome of probiotic and synbiotic therapy for inflammatory bowel diseases","volume":"8","author":"Sivamaruthi","year":"2018","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Xu, R., Lu, R., Zhang, T., Wu, Q., Cai, W., Han, X., Wan, Z., Jin, X., Zhang, Z., and Zhang, C. (2021). Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults. Commun. Biol., 4.","DOI":"10.1038\/s42003-021-01796-w"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1053\/j.gastro.2020.05.048","article-title":"Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization","volume":"159","author":"Zuo","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/gutjnl-2020-323020","article-title":"Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19","volume":"70","author":"Yeoh","year":"2021","journal-title":"Gut"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/S2666-5247(20)30009-4","article-title":"Co-infections: Potentially lethal and unexplored in COVID-19","volume":"1","author":"Cox","year":"2020","journal-title":"Lancet Microbe"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Galeeva, J.S., Fedorov, D.E., Starikova, E.V., Manolov, A.I., Pavlenko, A.V., Selezneva, O.V., Klimina, K.M., Veselovsky, V.A., Morozov, M.D., and Yanushevich, O.O. (2024). Microbial Signatures in COVID-19: Distinguishing Mild and Severe Disease via Gut Microbiota. Biomedicines, 12.","DOI":"10.3390\/biomedicines12050996"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2031840","DOI":"10.1080\/19490976.2022.2031840","article-title":"Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19","volume":"14","author":"Schult","year":"2022","journal-title":"Gut Microbes"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11684-022-0921-6","article-title":"Integrated analysis of gut microbiome and host immune responses in COVID-19","volume":"16","author":"Xu","year":"2022","journal-title":"Front. Med."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Righi, E., Lambertenghi, L., Gorska, A., Sciammarella, C., Ivaldi, F., Mirandola, M., Sartor, A., and Tacconelli, E. (2022). Impact of COVID-19 and Antibiotic Treatments on Gut Microbiome: A Role for Enterococcus spp.. Biomedicines, 10.","DOI":"10.3390\/biomedicines10112786"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/ibd\/izac135","article-title":"Efficacy of Fecal Microbiota Transplantation in the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials","volume":"29","author":"Chehade","year":"2023","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/apt.12365","article-title":"Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis","volume":"38","author":"Varela","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/cid\/ciaa663","article-title":"Metatranscriptomic Characterization of Coronavirus Disease 2019 Identified a Host Transcriptional Classifier Associated with Immune Signaling","volume":"73","author":"Zhang","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e2021378","DOI":"10.4322\/acr.2021.378","article-title":"Ulcerative colitis after SARS-CoV-2 infection","volume":"12","author":"Kartsoli","year":"2022","journal-title":"Autops. Case Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41579-020-0438-4","article-title":"Gut microbial metabolites as multi-kingdom intermediates","volume":"19","author":"Krautkramer","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","article-title":"The role of short-chain fatty acids in microbiota\u2013gut\u2013brain communication","volume":"16","author":"Dalile","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1053\/j.gastro.2021.10.013","article-title":"Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19","volume":"162","author":"Zhang","year":"2022","journal-title":"Gastroenterology"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Rocchi, G., Giovanetti, M., Benedetti, F., Borsetti, A., Ceccarelli, G., Zella, D., Altomare, A., Ciccozzi, M., and Guarino, M.P.L. (2022). Gut Microbiota and COVID-19: Potential Implications for Disease Severity. Pathogens, 11.","DOI":"10.3390\/pathogens11091050"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1053\/j.gastro.2020.06.048","article-title":"Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge","volume":"159","author":"Zuo","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Ancona, G., Alagna, L., Alteri, C., Palomba, E., Tonizzo, A., Pastena, A., Muscatello, A., Gori, A., and Bandera, A. (2023). Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1080043"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Ma\u0144kowska-Wierzbicka, D., Zuraszek, J., Wierzbicka, A., Gabryel, M., Mahadea, D., Baturo, A., Zakerska-Banaszak, O., Slomski, R., Skrzypczak-Zielinska, M., and Dobrowolska, A. (2023). Alterations in Gut Microbiota Composition in Patients with COVID-19: A Pilot Study of Whole Hypervariable 16S rRNA Gene Sequencing. Biomedicines, 11.","DOI":"10.3390\/biomedicines11020367"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.nutres.2021.09.001","article-title":"Vitamins, the gut microbiome and gastrointestinal health in humans","volume":"95","author":"Pham","year":"2021","journal-title":"Nutr. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1089\/ars.2012.4701","article-title":"How Can Faecalibacterium prausnitzii Employ Riboflavin for Extracellular Electron Transfer?","volume":"17","author":"Khan","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"eaau4732","DOI":"10.1126\/science.aau4732","article-title":"Effects of microbiota-directed foods in gnotobiotic animals and undernourished children","volume":"365","author":"Gehrig","year":"2019","journal-title":"Science"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/ejcn.2016.119","article-title":"The prebiotic concept and human health: A changing landscape with riboflavin as a novel prebiotic candidate?","volume":"70","author":"Steinert","year":"2016","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1875774","DOI":"10.1080\/19490976.2021.1875774","article-title":"Effects of colon-targeted vitamins on the composition and metabolic activity of the human gut microbiome\u2014A pilot study","volume":"13","author":"Pham","year":"2021","journal-title":"Gut Microbes"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1556\/1886.2019.00016","article-title":"Immunomodulatory and antimicrobial effects of vitamin C","volume":"9","author":"Mousavi","year":"2019","journal-title":"Eur. J. Microbiol. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.clnu.2016.06.029","article-title":"Associations between micronutrient intakes and gut microbiota in a group of adults with cystic fibrosis","volume":"36","author":"Li","year":"2017","journal-title":"Clin. Nutr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"876","DOI":"10.2174\/0929867323666161202150008","article-title":"Vitamin D\/VDR, Probiotics, and Gastrointestinal Diseases","volume":"24","author":"Shang","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Chatterjee, I., Lu, R., Zhang, Y., Zhang, J., Dai, Y., Xia, Y., and Sun, J. (2020). Vitamin D receptor promotes healthy microbial metabolites and microbiome. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-64226-7"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s00394-015-0966-2","article-title":"Effects of high doses of vitamin D3 on mucosa-associated gut microbiome vary between regions of the human gastrointestinal tract","volume":"55","author":"Bashir","year":"2016","journal-title":"Eur. J. Nutr."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.metabol.2017.01.007","article-title":"Gut microbiota interactions with the immunomodulatory role of vitamin D in normal individuals","volume":"69","author":"Luthold","year":"2017","journal-title":"Metabolism"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Naderpoor, N., Mousa, A., Arango, L.F.G., Barrett, H.L., Nitert, M.D., and de Courten, B. (2019). Effect of Vitamin D Supplementation on Faecal Microbiota: A Randomised Clinical Trial. Nutrients, 11.","DOI":"10.3390\/nu11122888"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1007\/s00394-018-1842-7","article-title":"Vitamin D and the gut microbiome: A systematic review of in vivo studies","volume":"58","author":"Waterhouse","year":"2019","journal-title":"Eur. J. Nutr."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Soltys, K., Stuchlikova, M., Hlavaty, T., Gaalova, B., Budis, J., Gazdarica, J., Krajcovicova, A., Zelinkova, Z., Szemes, T., and Kuba, D. (2020). Seasonal changes of circulating 25-hydroxyvitamin D correlate with the lower gut microbiome composition in inflammatory bowel disease patients. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-62811-4"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/MIB.0000000000000016","article-title":"Vitamin D Levels in Adults with Crohn\u2019s Disease Are Responsive to Disease Activity and Treatment","volume":"20","author":"Ham","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/ecco-jcc\/jjy052","article-title":"The Effect of Vitamin D on Intestinal Inflammation and Faecal Microbiota in Patients with Ulcerative Colitis","volume":"12","author":"Garg","year":"2018","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.clnu.2017.06.011","article-title":"Evaluation of a 12-week targeted vitamin D supplementation regimen in patients with active inflammatory bowel disease","volume":"37","author":"Garg","year":"2018","journal-title":"Clin. Nutr."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Abeles, S.R., Jones, M.B., Santiago-Rodriguez, T.M., Ly, M., Klitgord, N., Yooseph, S., Nelson, K.E., and Pride, D.T. (2016). Microbial diversity in individuals and their household contacts following typical antibiotic courses. Microbiome, 4.","DOI":"10.1186\/s40168-016-0187-9"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e035677","DOI":"10.1136\/bmjopen-2019-035677","article-title":"Antibiotic-induced changes in the human gut microbiota for the most commonly prescribed antibiotics in primary care in the UK: A systematic review","volume":"10","author":"Elvers","year":"2020","journal-title":"BMJ Open"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Khan, T.J., Hasan, M.N., Azhar, E.I., and Yasir, M. (2019). Association of gut dysbiosis with intestinal metabolites in response to antibiotic treatment. Hum. Microbiome J., 11.","DOI":"10.1016\/j.humic.2018.11.004"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Jakubczyk, D., Leszczy\u0144ska, K., and G\u00f3rska, S. (2020). The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)\u2014A Critical Review. Nutrients, 12.","DOI":"10.3390\/nu12071973"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41575-019-0173-3","article-title":"Probiotics and prebiotics in intestinal health and disease: From biology to the clinic","volume":"16","author":"Sanders","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Jadhav, A., Jagtap, S., Vyavahare, S., Sharbidre, A., and Kunchiraman, B. (2023). Reviewing the potential of probiotics, prebiotics and synbiotics: Advancements in treatment of ulcerative colitis. Front. Cell. Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1268041"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Bosselaar, S., Dhelin, L., Dautel, E., Titecat, M., Duthoy, S., Stelmaszczyk, M., Delory, N., Violante, M.D.S., Machuron, F., and Ait-Abderrahim, H. (2024). Taxonomic and phenotypic analysis of bifidobacteria isolated from IBD patients as potential probiotic strains. BMC Microbiol., 24.","DOI":"10.1186\/s12866-024-03368-4"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/2\/284\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:28:36Z","timestamp":1760027316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/2\/284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":54,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["medicina61020284"],"URL":"https:\/\/doi.org\/10.3390\/medicina61020284","relation":{},"ISSN":["1648-9144"],"issn-type":[{"type":"electronic","value":"1648-9144"}],"subject":[],"published":{"date-parts":[[2025,2,7]]}}}